Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-005187
Filing Date
2018-03-12
Accepted
2018-03-09 18:55:33
Documents
87
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K insy-10k_20171231.htm 10-K 4097279
2 EX-10.19 insy-ex1019_502.htm EX-10.19 120624
3 EX-23.1 insy-ex231_501.htm EX-23.1 3404
4 EX-31.1 insy-ex311_243.htm EX-31.1 9114
5 EX-31.2 insy-ex312_242.htm EX-31.2 8995
6 EX-32 insy-ex32_241.htm EX-32 9093
7 GRAPHIC g2018030922241140553077.jpg GRAPHIC 10609
8 GRAPHIC g2018030922242169553078.jpg GRAPHIC 28328
  Complete submission text file 0001564590-18-005187.txt   14361260

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT insy-20171231.xml EX-101.INS 3622837
10 XBRL TAXONOMY EXTENSION SCHEMA insy-20171231.xsd EX-101.SCH 63214
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20171231_cal.xml EX-101.CAL 78362
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20171231_def.xml EX-101.DEF 204313
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20171231_lab.xml EX-101.LAB 560568
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20171231_pre.xml EX-101.PRE 428142
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35902 | Film No.: 18681545
SIC: 2834 Pharmaceutical Preparations